Drugs News and Research

RSS

New cancer treatments use body's own immune system to kill melanoma tumours

Scientists are claiming that the body's own immune system could be used to fight the most serious form of skin cancer, malignant melanoma.

13 Nov 2006

Muscle protein myosin VI involved in the development of prostate cancer

Researchers at the Johns Hopkins Kimmel Cancer Center have for the first time implicated the muscle protein myosin VI in the development of prostate cancer and its spread.

8 Nov 2006

Inhibiting a particular cancer-causing gene improves radiation effectiveness

Inhibiting a particular cancer-causing gene can enhance the cell-killing effects of radiation, a team of radiation oncologists and cancer biologists at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia has found.

8 Nov 2006

Malawi needs to develop plan addressing country's AIDS orphans

The number of AIDS orphans in Malawi is a "potential looming catastrophe," and the country needs to develop a comprehensive action plan to address the situation, U.N. Special Envoy for HIV/AIDS in Africa Stephen Lewis said recently, the Chronicle/AllAfrica.com reports.

8 Nov 2006

Kaposi's sarcoma-associated herpesvirus tricks cells to become tumors

Researchers at the University of Pennsylvania School of Medicine have discovered how the Kaposi's sarcoma-associated herpesvirus (KSHV) subverts a normal cell process in order to promote tumor growth.

8 Nov 2006

Toyota builds employee health clinic in new factory to reduce health care costs

In an effort to contain health care spending, Toyota Motor will construct a $9 million medical clinic for employees and their families at its new San Antonio truck factory, the Detroit News reports.

8 Nov 2006

Problems with billing for Medicare prescription drug benefit premiums persist

About 50,000 of the 4.7 million Medicare beneficiaries who opted to have their Medicare prescription drug benefit premiums automatically withdrawn from their Social Security checks still are having incorrect amounts deducted, CMS officials said, USA Today reports.

8 Nov 2006

Shaped-beam radiosurgery treats tiniest lung tumors

Patients with metastatic cancer tumors in their lungs are much more likely to live disease-free if they have an experimental treatment involving shaped-beam radiosurgery rather that conventional treatment, according to a University of Rochester Medical Center study.

8 Nov 2006

Scientists discover how androgen plays a role in the development of prostate cancer

Scientists have discovered for the first time a specific biochemical pathway by which the sex hormone, androgen, increases levels of harmful chemicals called reactive oxygen species (ROS) in the prostate gland that play a role in the development of prostate cancer.

8 Nov 2006

Cardiologists say a dramatic change is needed in treating some heart patients

According to researchers at Johns Hopkins University in the U.S. a dramatic change is needed in the way hundreds of thousands of Americans with a form of heart failure should be treated.

8 Nov 2006

Arthritis drugs not as risky as first thought

Researchers now say that two biotech drugs used to treat rheumatoid arthritis, Humira (Abbott Laboratories) and Remicade (Johnson & Johnson), may not raise the risk of cancer and infections as much as was initially feared.

8 Nov 2006

UIC study evaluates two medications for ADHD

University of Illinois at Chicago researchers are comparing two drugs commonly used to treat attention deficit hyperactivity disorder to determine if genetic factors predict which children will respond to either or both drugs.

7 Nov 2006

Anabolic steroids and antisocial behaviour go together

Swedish researchers have found that there could well be a link between the use of anabolic steroids and antisocial behaviour.

7 Nov 2006

$70 million boost will help fight AIDS in Kenya

Kenya has been given $70 million from the Global Fund to fund programmes providing antiretroviral (ARV) drugs to people living with HIV.

7 Nov 2006

Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery

Though researchers have made substantial progress in developing drug-ferrying nanoparticles that successfully target tumor cells in living animals, including humans, investigators have only now started the detailed work needed to identify formulation parameters that would optimize drug delivery to malignant cells.

6 Nov 2006